Label Changes for:

Vfend (voriconazole) for Oral Suspension

May 2008

Changes have been made to the PRECAUTIONS sections of the safety label.


Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- May 2008

 

The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.


Summary View

Sections Modified

PRECAUTIONS

  • Drug Interactions
    • Table 12: Effect of Voriconazole on Pharmacokinetics of Other Drugs
      • Alfentanil (CYP3A4 Inhibition)

Label approved 05/30/2008 is not available on Drugs@FDA

Hide
(web3)